AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06509646 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Frenkel's Exercise
Description: Frenkel's exercises 30 minutes (Through these exercises, the patients would learn how to stay balanced and prevent falls by using their visual, somatosensory, and vestibular systems).~Treatment dosage will be 1 session per day of 1 hour class, 2 sets per session, and 5 repetitions per set, 3 times per week and for 12 weeks
Study NCT05993260 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural science-informed text messages
Description: Behaviourally-informed content in vaccination eligibility reminder text messages
Study NCT05993260 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Control vaccination eligibility reminder text message
Study NCT04827927 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Procedure: INTELLiVENT-ASV
Description: With INTELLiVENT-ASV, the patient's conditions, 'ARDS', 'Chronic Hypercapnia' or 'Traumatic Brain Injury' can be chosen, if applicable. The controllers for minute volume, PEEP and FiO2 are all activated, and the target shifts for etCO2 and SpO2 are adjusted, if necessary.
Study NCT04827927 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Procedure: Conventional ventilation
Description: With conventional ventilation, the same etCO2 and SpO2 levels are targeted as with INTELLiVENT-ASV, but here the caregiver is fully responsible for choosing the settings.
Study NCT05403125 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: silver diamine fluoride, 38%
Description: Topical application to all surfaces of the teeth
Study NCT05403125 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sodium fluoride gel, 5000 PPM
Description: Gel applied after application of silver diamine fluoride and dispensed for home use
Study NCT05403125 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sodium fluoride gel, 5000 PPM
Description: Gel applied after application of silver diamine fluoride and dispensed for home use
Study NCT04809207 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CF Wellness Program Sessions
Description: The intervention will last approximately 12 weeks. During this time, up to 9 coaching sessions will be delivered. Each will last approximately 45 - 60 minutes. Sessions will be delivered either by web-based video chat (e.g., Zoom) or by telephone. Sessions will cover content such as understanding the physiological, cognitive, affective, behavioral contributors to CF fatigue; understanding the role of physical activity/exercise and fatigue including the importance of balancing activity and rest periods; cognitive restructuring; addressing attention and interpretation processes contributing to fatigue; teaching techniques such as mindfulness meditation relaxation strategies, good sleep hygiene, and activity scheduling and behavioral activation; and engaging social support. Physical activity goals will be set each session. Participants will be encouraged to use the provided fitness tracker and to sync weekly prior the coaching session so that the results can inform session content.
Study NCT05647265 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT05647265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Procedure
Description: Undergo surgery
Study NCT05647265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: undergo CT
Study NCT05353712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CONTROL
Description: 35.7g sweet creme composed of 14.3g vegetable fat and 21.4g sucrose.
Study NCT05353712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ARA20
Description: 42.9g sweet creme composed of 14.3g vegetable fat, 21.4g sucrose and 7.1g L-arabinose
Study NCT05353712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ARA40
Description: 50g sweet creme composed of 14.3g vegetable fat, 21.4g sucrose and 14.3g L-arabinose
Study NCT05353712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TAG20
Description: 42.9g sweet creme composed of 14.3g vegetable fat, 21.4g sucrose and 7.1g D-tagatose
Study NCT05353712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TAG40
Description: 50g sweet creme composed of 14.3g vegetable fat, 21.4g sucrose and 14.3g L-arabinose
Study NCT04829799 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1% preservative-free lidocaine
Description: Instillation of intracameral lidocaine after initial paracentesis incision.
Study NCT04829799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenylephrine 1.0%/ Ketorolac 0.3%
Description: Instillation of Omidria irrigation solution after paracentesis incision and in irrigation solution.
Study NCT01045941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine/Gemzar
Description: Six cycles of Gemcitabine will be given. Each cycle of Gemcitabine comprises of Gemcitabine 1000 mg/m2 as a 30 minute infusion once weekly for 3 weeks with a fourth week off.
Study NCT01045941 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic Distal pancreatectomy
Description: Laparoscopic resection of the distal pancreas
Study NCT04997993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leflunomide
Description: Leflunomide, 20-50mg PO daily
Study NCT06034236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Task oriented resistance training will be performed, there will be 10 workstations:~1. Sitting at a table and reaching in different directions for objects located beyond arm's length.~2. Sit to stand from various chair heights~3. Stepping forward, backward and sideways onto blocks of various heights.~4. Heel lifts in standing~5. Standing with narrow base of support, feet in parallel and tandem stance and reaching for objects, including down to the floor.~6. Reciprocal leg flexion and extension.~7. Sit ups~8. Standing up from chair, walking a short distance and returning to the chair.~9. Walking races between participants~10. Walking over various surfaces and obstacles
Study NCT06034236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Otago Exercises
Description: It has total 17 exercises, out of which 12 exercises are performed to improve balance and 5 are performed to improve strength.~1. First component of intervention starts with head movements followed by neck movements, back extension, trunk movements and ankle movements.~2. Second component is muscle strengthening exercises, it includes: i. Front knee strengthening exercise ii. Back knee strengthening exercise iii. Side hip strengthening exercise iv. Calf raises (with support and without support) v. Toe raise (with support and without support). 3. Third component is balance exercises, it includes: i. Knee bends ii. Backward walking iii. Heel toe standing iv. Heel toe walking v. One leg stand vi. Heel walking vii. Sideways walk viii. Toe walking ix. Heel toe walking backwards x. Walk and turn around (figure of 8) xi. Sit to stand xii. Stair walks
Study NCT04566991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deferoxamine
Description: There will be 3 doses given to the patients days 1-3. Dose will be given intravenous with a fixed rate of 7.5 milligram per kilogram per hour (mg/kg/hr). The second dose will be given 24 hours after the first dose, and the third dose will be given 48 hours after the initial dose.~Patients will be randomized to 32 mg/kg or 48 mg/kg of Deferoxamine.
Study NCT06211595 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DragonFire Transcatheter Myocardial Radiofrequency Ablation System
Description: The patients with hypertrophic obstructive cardiomyopathy were treated with a transcatheter myocardial radiofrequency ablation system and its guiding system under the guidance of echocardiography
Study NCT04566991 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: There will be 3 doses given to the patients days 1-3. Dose will be given intravenous with a fixed rate of 7.5 mg/kg/hr. The second dose will be given 24 hours after the first dose, and the third dose will be given 48 hours after the initial dose.
Study NCT06028659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coffee
Description: Decaffeinated coffee with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Study NCT06028659 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Water
Description: 150 mL of hot water with 1 pack (5g) of sugar from commercially available brands prepared with commercially available domestic coffee machines.
Study NCT06074315 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nail Genesis DLSO Product
Description: Nail fungus is difficult to treat with topical drugs because of the thickness of the nails (Murdan, 2002). Nail Genesis DLSO Product does not contain a drug or antifungal agent and so is not designed to have a direct action on the microorganism, but instead will act by changing the conditions that allow growth of the fungus (i.e., keeping the nail plate and underlying nail bed dry and inhibiting secondary infection).
Study NCT06074315 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nail Genesis DLSO Product (vehicle only)
Description: The Nail Genesis DLSO product poly-urethane vehicle
Study NCT05950009 — intervention group
Intervention type: OTHER
Intervention: No intervention (observational studies)
Description: No intervention (observational studies)
Study NCT05427253 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C106 solution
Description: selective nonpeptide angiotensin II type 2 receptor (AT2R) agonist
Study NCT05427253 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for C106 solution
Study NCT06507592 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Saliva samples collection
Description: The first sample of saliva was be taken before the start of the treatment and considered as the control sample (T0); the second sample was be taken one month after the start of the treatment (T1) and the third one after three months (T2).
Study NCT05729659 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sideritis Scardica (SidTea+) extract supplementation
Description: 1500 mg of Sideritis Scardica (SidTea+) extract per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month
Study NCT05729659 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplementation
Description: 1500 mg of placebo per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month
Study NCT06474585 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Plantar orthosis
Description: Plantar orthosis taken in sitting position Plantar orthosis taken in standing position
Study NCT06474585 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Plantar orthosis
Description: Plantar orthosis taken in sitting position Plantar orthosis taken in standing position
Study NCT05647265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05647265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT06231615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fascia exercises
Description: Fascia exercises are slow and calm movements similar to yoga performed by the person herself/himself.
Study NCT06231615 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional physiotherapy and breathing exercises
Description: Head and neck exercises and breathing exercises
Study NCT06231615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy and breathing exercises
Description: Head and neck exercises and breathing exercises
Study NCT05585697 — intervention group
Intervention type: OTHER
Intervention: None - crossectional
Description: None - crossectional
Study NCT06434844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Auricular acupunctures
Description: After disinfection of the external ear with 75% alcohol wipes, 018x 13 filiform needles (Mocm International Limited) will be used to perform the auricular acupunctures at the relaxation point, tranquilizer point and master cerebral point at the left and right external ears.
Study NCT06434844 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Auricular acupunctures
Description: After disinfection of the external ear with 75% alcohol wipes, 018x 13 filiform needles (Mocm International Limited) will be used to perform the auricular acupunctures at the relaxation point, tranquilizer point and master cerebral point at the left and right external ears.
Study NCT06434844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham acupunctures
Description: The auricular acupoints of finger, shoulder and tonsil will be targeted instead. These points are also located at the external ear and comparable to those in the intervention group. The external ear will be disinfected with 75% alcohol wipes. Auricular acupunctures with 018x 13 filiform needles (Mocm International Limited) will be carried out at the finger point, shoulder point and tonsil point of the left and right external ears.
Study NCT06434844 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham acupunctures
Description: The auricular acupoints of finger, shoulder and tonsil will be targeted instead. These points are also located at the external ear and comparable to those in the intervention group. The external ear will be disinfected with 75% alcohol wipes. Auricular acupunctures with 018x 13 filiform needles (Mocm International Limited) will be carried out at the finger point, shoulder point and tonsil point of the left and right external ears.
Study NCT04825418 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artic Sun
Description: 1. Induction phase A. Temperature using by esophageal or bladder thermometer. B. Application of a surface cooling device (Arctic Sun) C. Target temperature: 35 ± 0.5 °C D. Induction should be initiated as soon as possible after surgery (less than 6 hours)~2. Maintain phase A. Maintain duration : at least 72 hours and duration can be prolonged according to patient's clinical status B. Use the bedside shivering assessment scale (BSAS) and anti-shivering protocol C. Neuromuscular blocker can be used according to the discretion of the attending physician D. Lung-protective ventilation strategies including low-tidal volume are recommended E. Prophylactic antibiotics can be used to prevent pneumonia during hypothermia~3. Rewarming phase A. Rewarming rate: 0.05 - 0.1 ℃/hr (about 20 - 40 hours) to 37 ℃
Study NCT04381637 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIPE monitor
Description: NIPE monitor connected to the anesthetic station. No part of the device in contact with the patient. No action on patient or anesthesia. Automatic recording of Heart rate and NIPE index during the study period.
Study NCT04381637 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tetanic stimulations
Description: Three tetanic stimulations will be performed (10-30 and 60 milliamps) under general anesthesia, before surgical incision.~Stims performed via the muscle relaxation monitor (used in standard practice in this population) Each stim lasts for 5 seconds. Interval between two stims : 3-5 minutes Order on intensities randomized by a latin square of order 3.
Study NCT06464900 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Routine Care
Description: Provide patients with regular medication guidance, dietary guidance, exercise guidance and knowledge about diabetes mellitus and hypoglycaemia; test and record blood glucose regularly every day; answer patients' clinical questions and provide psychological support in a timely manner.
Study NCT06464900 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Based on BCW Theory of Health Education
Description: BCW theory was applied to analyse behaviour and develop interventions in terms of capability, motivation and opportunity. Capability: Intensive daily management of diabetes through intervention functions (education, training, persuasion, modelling) to change attitudes and habits, understand the negative consequences of fear of hypoglycaemia, improve hypoglycaemia awareness and self-regulation skills. Opportunity: Through the intervention function (education, training, realization) to improve the awareness of hypoglycemia awareness, timely detection of hypoglycemia. In the event of a hypoglycaemic event patients know how to deal with it. Motivation: Through intervention functions (environmental reconstruction, realisation) that take full account of external factors and their own opportunities. Glucose management through microsoft platforms, on-site teaching and coaching by specialist nurses to create opportunities for patients who can change excessive/avoidant behaviours.
Study NCT05851872 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary angiogram
Description: Being done per standard of care
Study NCT05851872 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronary angiogram
Description: Being done per standard of care
Study NCT05851872 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Right heart catheterization
Description: Being done per standard of care
Study NCT05851872 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Right heart catheterization
Description: Being done per standard of care
Study NCT05061745 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Guided Meditation VR for Wellness
Description: Selected Modules of Commercially Available Guided Meditation VR presented on Valve Index Headset
Study NCT05061745 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Accelerated Transcranial Magnetic Stimulation: Treatment A
Description: Either MagVenture Transcranial Magnetic Stimulation (Treatment Coil Cool B70 AP) or The NeuroStar® System will be used.
Study NCT05061745 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Accelerated Transcranial Magnetic Stimulation: Treatment B
Description: Either MagVenture Transcranial Magnetic Stimulation (Cool D-B80 AP) or The NeuroStar® System will be used.
Study NCT05625672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training
Description: Hemovigilance module training
Study NCT05819515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tunneled coronally advanced flap
Description: Describes the flap design for both treatment arms
Study NCT05819515 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tunneled coronally advanced flap
Description: Describes the flap design for both treatment arms
Study NCT05062681 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Patients will receive dexamethasone 8 mg q12hours
Study NCT05062681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Patients will receive 1mg/kg/day in 2 divided doses over 30 minutes
Study NCT06391723 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS
Description: rTMS will be administered over the left dorsolateral prefrontal cortex (20 Hz, 90% resting motor threshold, 20 2 s trains with 60-s intervals, 800 pulses/session)
Study NCT06391723 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham rTMS
Description: Sham rTMS will be administered over the left dorsolateral prefrontal cortex
Study NCT05807100 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Baseline Standardized Mini Mental Test
Description: Cognitive status assessment was done with Standardized Mini Mental Test.
Study NCT05807100 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 6th month Standardized Mini Mental Test
Description: Cognitive status assessment was done with Standardized Mini Mental Test.
Study NCT05235958 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-linear periodized exercise (NLPE)
Description: Aerobic training derived from professional sports, that is characterized by variable periodization of training frequency, volume and intensity according to individual factors, such as physical and mental readiness, training progress and performance level
Study NCT05235958 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Exercise counselling
Description: Standard recommendations for exercise and physical activity, that are individualized according to a medical health and fitness profile
Study NCT06219837 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: bupivacaine injection by ultrasound guided transversalis fascia plane block
Description: With patients in a sitting position and after appropriate skin asepsis, a 25-G pencil-point spinal needle (Pencil Point Spinal Needle Set, Egemen International Ltd., Izmir, Turkey) will be inserted through the L3 to L4 or L4 to L5 intervertebral space and 15 mg of 0.5% hyperbaric bupivacaine (AstraZeneca Pharmaceuticals, Cambridge, United Kingdom) will be injected. Subsequently, the patients will be positioned supine.
Study NCT06219837 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine injection by ultrasound guided transversalis fascia plane block
Description: With patients in a sitting position and after appropriate skin asepsis, a 25-G pencil-point spinal needle (Pencil Point Spinal Needle Set, Egemen International Ltd., Izmir, Turkey) will be inserted through the L3 to L4 or L4 to L5 intervertebral space and 15 mg of 0.5% hyperbaric bupivacaine (AstraZeneca Pharmaceuticals, Cambridge, United Kingdom) will be injected. Subsequently, the patients will be positioned supine.